21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN DOMESTIC ANIMALS AND IMPROVED CELL CULTIVATION METHODS
#1802COMBINATIONAL TCR-T CELL THERAPY TARGETING TUMOR ANTIGENS, TGF-BETA, AND IMMUNE CHECKPOINTS
#1803CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF
#1804COMBINATION OF A GREMLIN-1 ANTAGONIST WITH A CYTIDINE ANALOGUE OR DEOXYCYTIDINE ANALOGUE
#1805sGC STIMULATORS
#1806ORGANIC COMPOUNDS
#1807sGC STIMULATORS
#1808(S)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-2-FLUORO-5,6,7,8,9,10-HEXAHYDROCYCLO HEPTA[B]INDOLE-4-CARBOXAMIDE, AND RELATED CRYSTALLINE FORMS, COMPOSITIONS, AND METHODS THEREOF
#1809LIPID COMPOSITION AND METHOD OF DELIVERING THERAPEUTIC AGENT
#1810ALLOGENEIC HYPOIMMUNE BIOMIMETIC NANOVESICLE FOR THE TREATMENT OF CANCER
#1811ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODY AGAINST HUMAN TROP2 AND USE THEREOF
#1812ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#1813RAS INHIBITORS
#1814HISTAMINE AND HRH1 SIGNALING ACTIVITY AS BIOMARKERS AND ASSOCIATED METHODS
#1815FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
#1816GENE DELIVERY SYSTEM
#1817ANTI-NET COMPOUNDS FOR TREATING AND PREVENTING FIBROSIS AND FOR FACILITATING WOUND HEALING
#1818COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION
#1819TOPICAL ANTIBIOTIC
#1820EXTRACT OF BETA-GLUCAN-RICH SACCHAROMYCES CEREVISIAE YEAST CELL WALLS IN THE PREVENTION OF THE TOXIC EFFECTS OF MYCOTOXIN DEOXYNIVALENOL (DON)
#1821COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATION
#1822Engineered Extracellular Vesicle Delivery Systems and Uses Thereof
#1823BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS
#1824METHODS OF P21 SUPPRESSION FOR BONE REGENERATION AND HEALING
#1825A DUAL SELECTIVE PI3K DELTA AND GAMMA INHIBITORS AND/OR A SALT-INDUCIBLE KINASE 3 INHIBITOR FOR TREATING SOLID TUMORS
#18267-BENZYL-4-(METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E] PYRIMIDIN-5 (1 H)-ONE, SALTS THEREOF AND METHODS OF USING THE SAME IN COMBINATION THERAPY
#1827SMALL MOLECULE ENHANCERS OF ANTISENSE OLIGO ACTIVITY
#1828COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS
#1829TREATMENT OF SYSTOLIC DYSFUNCTION
#1830L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB)
#1831PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1832THERAPEUTIC METHODS USING DECANOIC ACID AND AMINO ACIDS
#1833COMPOSITIONS AND METHODS COMPRISING DEOXY-PENTITOLS
#1834METHOD OF DELIVERY OF DNA OR RNA CARGO USING UNSHIELDED LIPID NANOPARTICLES AND COMPOSITIONS THEREOF
#1835NANOSTRUCTURED LIPID CARRIERS AND STABLE EMULSIONS AND USES THEREOF
#1836TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRBeta ANTIBODY
#1837Combination Therapies And Patient Stratification With Bispecific Ant-EGFR/C-MET Antibodies
#1838CD229 Car T Cells And Methods Of Use Thereof
#1839Antibodies Against Human Siglec-7 and Use Thereof for Immunotherapy
#1840THERAPEUTIC COMBINATIONS AND METHODS TO TREAT LONG COVID
#1841PDL2 COMPOUNDS
#1842BETA-LACTAMASE INHIBITORS
#1843BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES
#1844DEUTERATED BENZODIAZEPINE ANALOGS AND METHODS OF USE IN TREATING CANCER
#1845METHOD FOR THE TREATMENT OF MALARIA
#1846SYSTEMS AND METHODS FOR IMPROVED PAIN RELIEF FROM STIMULATION OF THERMAL FIBERS
#1847METHODS FOR IMPROVING ADENO-ASSOCIATED VIRUS (AAV) DELIVERY
#1848ABHD18 inhibitors
#1849TREATMENT OF CANCER USING A COMBINATION OF IMMUNOMODULATION AND CHECK POINT INHIBITORS
#1850Method for preparing tumor vaccine using magnetic thermal inactivation technology
#1851MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
#1852CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF)
#1853Methods and Compositions for Treating or Preventing Neurological Injury or Neurological Disorders
#1854AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE INTRANASAL SYSTEM
#1855CHIMERIC ANTIGEN RECEPTOR MODIFIED REGULATORY T CELLS FOR TREATING CANCER
#1856ANTI-RETROVIRAL THERAPIES AND REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE
#1857Benzimidazole derivatives for use in the treatment or prevention of a histiocytosis or a craniopharyngioma
#1858METHODS OF USE FOR AZA-QUINAZOLINE COMPOUNDS
#1859METHODS OF TREATING OCULAR CONDITIONS
#1860NOVEL PHARMACEUTICAL FORMULATION
#1861Compositions and Methods for Treatment of Edema
#1862INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
#1863METHODS OF TREATING CANCERS
#1864MODULATION OF HUMAN BREAST MILK COMPOSITION
#1865TAMPER RESISTANT DOSAGE FORMS
#1866ORAL PRODUCTS AND METHODS OF MANUFACTURE
#1867DISSOLVABLE-CHEWABLE TABLET
#1868METHODS AND COMPOSITIONS FOR TREATING CANCER
#1869TREATMENT FOR ACUTE MYELOID LEUKEMIA WITH ANTI-CD70 ANTIBODIES
#1870ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS
#1871TREATMENT OF PERIVASCULAR FIBROSIS AND OTHER HYPERTENSIVE DISEASES AND CONDITIONS
#1872PDL1 PEPTIDES FOR USE IN CANCER VACCINES
#1873PROTEIN TYROSINE-TYROSINE ANALOGS AND METHODS OF USING THE SAME
#1874METAGENOME-GUIDED BIOSYNTHESIS AND COMPOUNDS AND METHODS OF USE THEREOF
#1875SALT FORMS OF AN AXL INHIBITOR
#1876QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
#1877MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS
#1878ENGINEERING SUICIDE GENE APPROACHES TO IMPROVE CHEMOTHERAPEUTIC RESPONSE IN CANCER
#1879TUMOR-INTRINSIC GALECTIN-3 SUPPRESSES MELANOMA METASTASIS
#1880HYDROGEL PRODRUG FOR TREATMENT
#1881HYDROGEL PRODRUG FOR TREATMENT
#1882METHODS OF TREATING OR PREVENTING STENT THROMBOSIS
#1883ANTI-CD3 ANTIBODY FORMULATIONS
#1884NEOANTIGENS AND USES THEREOF
#1885COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS
#1886IMMUNE ENHANCEMENT AND INFECTIOUS DISEASE TREATMENT
#1887A METHOD OF TREATING OR PREVENTING SEPSIS
#1888MICROBIAL COMMUNITIES THAT INHIBIT CLOSTRIDIOIDES DIFFICILE AND METHODS OF USING SAME
#1889AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES
#1890METHODS AND COMPOSITIONS FOR NON-MYELOABLATIVE BONE MARROW RECONSTITUTION
#1891VAGINAL CARE COMPOSITIONS AND METHODS OF IMPROVING VAGINAL HEALTH
#1892METHODS AND COMPOSITIONS FOR TREATING HEART CONDITIONS
#1893ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#1894ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS
#1895COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME
#1896Methods and Products to Screen and Treat Glioblastoma Multiforme and Other Cancers, Including Breast Cancers, Using A Combination of PI3KINASE Inhibitors With Checkpoint Inhibitors
#1897COMPOSITIONS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES
#1898METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
#1899PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLON AND LUNG CANCER
#1900METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#1901METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED PROTOPORPHYRIA, OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT INHIBITORS
#1902COMBINATION OF A GREMLIN-1 ANTAGONIST WITH AN INHIBITOR OF RAS-RAF-MEK-ERK SIGNALLING
#1903COMPOSITIONS COMPRISING ATICAPRANT
#1904ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
#1905ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
#1906METHODS OF ADMINISTRATION FOR HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER
#1907PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY
#19082,4-Dinitrophenol Formulations and Methods Using Same
#1909WATER-BASED FORMULATION OF DISCREET LIQUID PATCH FOR THE PAIN-FREE TREATMENT OF COLD SORES
#1910PARTICLES COMPRISING A THERAPEUTIC OR DIAGNOSTIC AGENT AND SUSPENSIONS AND METHODS OF USE THEREOF
#1911COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#1912COMPOSITIONS AND METHODS FOR DRUG INSTILLATION INTO THE URINARY BLADDER
#1913PREPARATION AND ANTI-TUMOR APPLICATION OF GENE THERAPY VECTOR INTERFERING CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING PROTEIN 6 (CMTM6) EXPRESSION
#1914EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS
#1915MONOCLONAL ANTIBODIES AND BISPECIFIC ANTIBODY AGAINST C-MET
#1916NOVEL ANTI-CD3 ANTIBODIES AND USES THEREOF
#1917PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER
#1918BIFUNCTIONAL FUSION PROTEIN COMPOSED OF IL-15 AND ANTIBODY AGAINST T CELL CO-STIMULATORY MOLECULE
#1919TRUNCATED DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR DECREASING VIABILITY OF NEOPLASTIC CELLS
#1920MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF
#1921TRICYCLIC BORONIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#1922INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
#1923COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#1924METHODS FOR MAKING AND USING ENDOXIFEN
#1925COMPOSITIONS AND METHODS FOR TARGETED TREATMENT AND IMAGING OF CANCER TUMORS
#1926COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TRANSPLANT-ASSOCIATED INJURY
#1927Beta-Lactam-Cannabinoid Conjugate Molecules
#1928Composition and Methods for Preventing and Treating African Swine Fever in Wild and Domestic Swine
#1929TUBERCULOSIS VACCINES
#1930METHODS AND COMPOSITIONS FOR TREATING MYELOFIBROSIS
#1931Chlorella and Corn Leaf Extract Compositions, Their Production, and Methods of Use
#1932COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER USING COMBINED THERAPY, COMPRISING LACTOBACILLUS PLANTARUM STRAIN AND ANTICANCER DRUG
#1933PROCESSES FOR MAKING AND USING A MESENCHYME STEM CELL SECRETOME FOR LIMBAL STEM CELL DEFICIENCY (LSCD) TREATMENT
#1934Treatment of Disc Degeneration using B Regulatory Cells
#1935METHOD AND COMPOSITION FOR TREATING CORONA VIRUS, INFLUENZA, AND ACUTE RESPIRATORY DISTRESS SYNDROME
#1936ORAL COMPOSITION CONTAINING DIMETHYLGLYCINE FOR IMPROVING THE CONDITION OF THE HAIR AND SCALP
#1937METHODS OF USING AVERMECTIN COMPOSITIONS FOR THE TREATMENT OF PAIN AND DOSING REGIMENS
#1938Methods for Treating Immune Thrombocytopenia by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy- Phenyl) Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile
#1939Methods Of Treating Depression Using Orexin-2 Receptor Antagonists
#1940COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES
#1941FABP4 AS A THERAPEUTIC TARGET IN SKIN DISEASES
#1942Pharmaceutical Combinations For The Treatment Of Cancer
#1943PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
#1944INTRANASAL ADMINISTRATION OF N-ACETYLCYSTEINE AND USES THEREOF
#1945METHODS FOR TREATING A CORONAVIRUS INFECTION USING VALPROIC ACID AND DOCOSAHEXAENOIC ACID
#1946IMMUNE ENHANCEMENT OF CANCER TREATMENT
#1947BOOSTING OSMOTIC BLOOD-ORGAN BARRIER OPENING FOR IMPROVED DELIVERY OF THERAPEUTICS TO ORGANS
#1948INTEGRATION OF TUMOR CHARACTERISTICS WITH BREAST CANCER INDEX
#1949LIVER PROTECTIVE MARC VARIANTS AND USES THEREOF
#1950ANTI-HELICASE THERAPY FOR TREATMENT OF REPEAT EXPANSION DISEASE
#1951METHOD OF TREATING CHRONIC HEPATITIS B
#1952COMPOSITION AND METHOD FOR INHIBITING ANGIOTENSINOGEN (AGT) PROTEIN EXPRESSION
#1953FUSION PROTEINS AND USES THEREOF
#1954COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES
#1955DR5 Agonist and PLK1 Inhibitor or CDK Inhibitor Combination Therapy
#1956COMPOSITIONS AND METHODS FOR TREATING IMMUNE THROMBOCYTOPENIA
#1957COMBINATION THERAPY OF KRAS INHIBITOR AND TREG DEPLETING AGENT
#1958ANTI-PD-1 ANTIBODY FORMULATIONS
#1959ANTIBODIES SPECIFICALLY BINDING PD-1, TIM-3 OR PD-1 AND TIM-3 AND THEIR USES
#1960COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA
#1961ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF
#1962LYSINE RICH CELL-PENETRATING PEPTIDES
#1963NUCLEOSIDES FOR TREATING CANCER
#1964CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE
#1965SUBSTITUTED TRICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF
#1966SALTS AND SOLID FORMS OF AN ESTROGEN RECEPTOR ANTAGONIST
#1967NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER
#1968MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER
#1969COMPOUNDS DERIVED FROM 4-AMINO-N-(4-AMINOPHENYL) BENZAMIDE AND ANALOGUES AND USE THEREOF
#1970PYRIDINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS
#1971INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE
#1972TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
#1973METHODS TO MITIGATE SIDE EFFECTS OF CANCER TREATMENTS
#1974TREATING METASTATIC CANCER AND MODEL SYSTEMS FOR METASTATIC DISEASE
#1975RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES
#1976COMPOSITIONS INCLUDING IFNE AND USES THEREOF
#1977METHODS AND COMPOSITIONS FOR LOCALIZED PRODUCTION AND DELIVERY OF BIOLOGICAL MOLECULES
#1978ANTI-EGFR ANTIBODY DRUG CONJUGATES
#1979COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
#1980NOVEL APPROACH FOR TREATMENT OF CANCER USING IMMUNOMODULATION
#1981METHODS FOR INHIBITING TRAINED IMMUNITY WITH NANOBIOLOGIC COMPOSITIONS
#1982ENHANCED DELIVERY OF ANTIOXIDANTS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS INVOLVING OXIDATIVE STRESS
#1983PEPTIDES AND METHODS FOR USE IN TREATING PAIN
#1984CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE
#1985COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF
#1986RECOMBINANT MICROORGANISM-BASED METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASE
#1987COMPOSITIONS AND METHODS FOR TREATING A REFRACTORY OR RELAPSED CANCER OR A CHRONIC INFECTIOUS DISEASE
#1988VANADYL SULFATE COMPOSITIONS AND METHODS OF USE THEREFOR FOR THE TREATEMENT AND PREVENTION OF AGING-RELATED DISEASES AND CANCER
#1989PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
#1990PHARMACEUTICAL COMPOSITIONS FOR DEMODEX RELATED BLEPHARITIS AND EYELID CRUSTING
#1991Use of Derivatives based on Sarsasapogenin Structure and Pharmaceutical Compositions thereof
#1992PHARMACEUTICAL COMPOSITION COMPRISING CURCUMIN AND GINSENOSIDE, AND FORMULATION THEREOF
#1993COMBINATION THERAPIES
#1994ALPHA POLYGLUTAMATED AMINOPTERIN AND USES THEREOF
#1995METHODS AND COMPOSITIONS FOR MEASURING AND INHIBITING EXONUCLEASE ACTIVITY
#1996COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEUROGENERATIVE DISEASE
#1997COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CYTOKINE RELEASE SYNDROME
#1998ALK5 INHIBITORS AS SKELETAL MUSCLE HYPERTROPHY INDUCERS
#1999COMPOSITIONS FOR USE
#2000COMBINATION OF HDAC INHIBITORS AND STATINS FOR USE IN THE TREATMENT OF PANCREATIC CANCER
#2001LYMPH DIRECTING PRODRUGS
#2002SYNERGY FOR INCREASING INSULIN SENSITIVITY
#2003METHODS FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME
#2004BACTERICIDAL AND VIRUCIDAL PHARMACEUTICAL COMPOSITION
#2005SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#2006SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#2007OXYGEN-ENHANCED ADAPTIVE FUNCTIONAL BEVERAGE FOR ANTI-AGING AND METHOD OF PREPARATION
#2008SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS
#2009COMPOUNDS AND COMPOSITIONS INCLUDING PHOSPHOROTHIOATED OLIGODEOXYNUCLEOTIDE, AND METHODS OF USE THEREOF
#2010MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN HUMANS AND IMPROVED CELL CULTIVATION METHODS
#2011THERAPEUTIC INHIBITION OF CD38 TO TREAT HIDRADENITIS SUPPURATIVA
#2012USE OF IRE1ALPHA-XBP1 SIGNALING PATHWAY BIOMARKERS FOR MODULATING IMMUNE RESPONSES
#2013ANGIOTENSIN-(1-9) ANALOGUE BASED ON D AMINO ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#2014C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS
#2015NLRP3 INFLAMMASOME INHIBITORS
#2016MODULATORS OF THR-BETA AND METHODS OF USE THEREOF
#2017SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS
#2018SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS
#2019PORTABLE DRUG MIXING AND DELIVERY DEVICE AND ASSOCIATED METHODS
#2020PHOTOACTIVATABLE NANOPARTICLES AND USES THEREOF AS AGENTS FOR IMMUNOTHERAPY COMBINATIONS
#2021METHODS AND SYSTEMS FOR APPLICATIONS INVOLVING ANTIGEN-PRESENTING CELLS
#2022BI-FUNCTIONAL MOLECULES TO DEGRADE CIRCULATING PROTEINS
#2023COMBINATION THERAPY OF AN ANTI CD20 ANTIBODY WITH A BTK INHIBITOR
#2024METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS
#2025SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION
#2026ARGINASE1 POLYPEPTIDES
#2027COLLOIDAL FIBRIN NANOPARTICLE COMPOSITIONS AND USES
#2028NONPOLYMERIZABLE FIBRINOGEN AS AN ANTITHROMBOTIC AGENT
#2029PLANT-BASED COMPOSITIONS AND METHODS FOR HORMONE SIGNALING, BLOOD GLUCOSE CONTROL, APPETITE CONTROL, AND WEIGHT MANAGEMENT
#2030USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#2031COMPOSITIONS, REAGENTS, AND METHODS FOR TREATING PITT-HOPKINS SYNDROME
#2032FORMULATIONS FOR TREATMENT OF XEROSTOMIA, AND METHODS THEREFOR
#2033MICRORNAS FOR INHIBITING THE EXPRESSION OF TRF2 IN TUMORS
#2034ASPERULOSIDE AS AN AGENT FOR IMPROVING VASCULAR AND METABOLIC FUNCTION IN OBESITY: ROLE OF NRF2 ACTIVATION
#20357-KETOLITHOCHOLIC ACID FOR USE IN THE TREATMENT OF GUT DYSBIOSIS AND AS A PREBIOTIC
#2036COMBINATIONS
#2037METHODS OF TREATING DISORDERS USING CSF1R INHIBITORS
#2038DOSE REGIMEN FOR VERICIGUAT
#2039Methods of Treating a Subject for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Compositions for Use in The Same
#2040METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING FIBROSIS AND IMPROVING FUNCTIONAL RECOVERY AFTER INJURY OR WITH AGING
#2041TREATMENT OR PREVENTION OF RESPIRATORY DISEASES CHARACTERISED BY, OR INVOLVING, LUNG FIBROSIS
#2042METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS
#2043DELMOPINOL AND DELMOPINOL SALT CONTAINING NANOPARTICLES AND USES THEREOF
#2044ENGINEERED EXTRACELLULAR VESICLES FOR TARGETED DRUG DELIVERY TO MUSCLE
#2045FORMULATIONS COMPRISING MELPHALAN FLUFENAMIDE AND CYCLODEXTRIN
#2046Heparanase Inhibition for Graft Protection
#2047METHOD AND BIOMARKER FOR PREDICTING SEVERITY OF COVID-19 DISEASE AND METHOD FOR THERAPEUTIC INTERVENTION IN COVID-19 DISEASE
#2048SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF
#2049PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
#2050PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
#2051PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
#2052PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
#2053PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
#2054HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONS
#2055HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR
#2056OSMR-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE
#2057METHODS FOR THE TREATMENT OF THYROID EYE DISEASE
#2058METHODS FOR IN VIVO EXPANSION OF CD8+ T CELLS AND PREVENTION OR TREATMENT OF GVHD
#2059PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITION
#2060TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR
#2061MCL1 INHIBITORS
#2062Polymorphic Compounds And Uses Thereof
#2063COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS
#2064INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS FOR USING SAME
#2065NOVEL PHARMACEUTICAL SALTS AND POLYMORPHIC FORMS OF AN ERBB AND BTK INHIBITOR
#2066PYRAZINE AMIDE DERIVATIVES
#2067TEAD Targeting Compounds and Methods Thereof
#2068METHOD OF TREATING OCULAR DISORDERS WITH COMPOUNDS FOUND IN HARDERIAN GLAND SECRETIONS
#2069MICRO- AND NANO-FLUIDIC CHIP, METHOD OF FABRICATING THE SAME, AND APPLICATIONS THEREOF
#2070MICRO- AND NANO-FLUIDIC CHIP, METHOD OF FABRICATING THE SAME, AND APPLICATIONS THEREOF
#2071D GLUTAMATE POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#2072DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS TO NEURONS
#2073RAS INHIBITORS
#2074THERAPEUTIC COMPOSITION AND METHOD COMBINING MULTIPLEX IMMUNOTHERAPY WITH CANCER VACCINE FOR THE TREATMENT OF CANCER
#2075Compositions For and Methods of Preventing Metastases
#2076IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE
#2077COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR TREATMENT OF GRAFT VERSUS HOST DISEASE
#2078ANALYTICAL METHOD AND THERAPEUTICAL AGENT FOR USE IN COMBINATION WITH L-ASPARAGINASE IN TUMOUR THERAPY
#2079METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY
#2080USES OF PTHRP ANALOGUE IN REDUCING FRACTURE RISK
#2081USE OF ANNEXINS IN PREVENTING AND TREATING CARDIAC NEURONAL CELL MEMBRANE INJURY AND DISEASE
#2082Therapeutic Compositions for the Treatment of Dry Eye Disease
#2083COMPOSITION FOR PREVENTING OR TREATING DENTAL CARIES
#2084Compositions and Methods for Treating Neuropathy
#2085Pharmaceutical Composition for Postpartum Recovery and Treatment of Pelvic Floor Dysfunction
#2086COMPOSITIONS AND METHODS OF TREATMENT FOR CONGENITAL DIARRHEAL DISORDER
#2087BETULIN-CONTAINING BIRCH BARK EXTRACTS AND THEIR FORMULATION
#2088DOSE REGIMEN OF VICASINABIN
#2089METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS
#2090ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OF SYSTEMIC DISEASES IN CATS
#2091COMBINATION THERAPY USING A PTPN11 INHIBITOR AND AN EGFR INHIBITOR
#2092METHODS OF TREATING CHOLANGIOCARCINOMA
#2093USE OF DEXTROMETHORPHAN IN COMBINATION WITH CYP2D6 AND CYP3A4 ENZYME INHIBITORS FOR THE TREATMENT OF PAIN
#2094USE OF IPTACOPAN FOR THE TREATMENT OF LUPUS NEPHRITIS
#2095MEDICINE CONTAINING VITAMIN D DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, USED IN COMBINATION WITH IMMUNOMODULATORY SUBSTANCE
#2096MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
#2097Piezo Inhibition for Wound Healing
#2098ASYMMETRIC ALLYL TRYPTAMINES
#2099FORMULATIONS COMPRISING TRIPTAN COMPOUNDS
#2100METHODS AND COMPOSITIONS FOR TREATING COLORECTAL CANCER WITH INDOXYL SULFATE